HK1245401A1 - 鑑定、選擇和使用高治療潛力的t細胞表位 - Google Patents

鑑定、選擇和使用高治療潛力的t細胞表位

Info

Publication number
HK1245401A1
HK1245401A1 HK18104738.9A HK18104738A HK1245401A1 HK 1245401 A1 HK1245401 A1 HK 1245401A1 HK 18104738 A HK18104738 A HK 18104738A HK 1245401 A1 HK1245401 A1 HK 1245401A1
Authority
HK
Hong Kong
Prior art keywords
identification
selection
cell epitopes
high curative
curative potential
Prior art date
Application number
HK18104738.9A
Other languages
English (en)
Inventor
Nancy Parenteau
Joseph Laning
Janet Young
Original Assignee
Verik Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verik Bio Inc filed Critical Verik Bio Inc
Publication of HK1245401A1 publication Critical patent/HK1245401A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hospice & Palliative Care (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK18104738.9A 2014-12-03 2018-04-11 鑑定、選擇和使用高治療潛力的t細胞表位 HK1245401A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462087002P 2014-12-03 2014-12-03
PCT/US2015/063810 WO2016090177A1 (en) 2014-12-03 2015-12-03 Identification, selection and use of high curative potential t cell epitopes

Publications (1)

Publication Number Publication Date
HK1245401A1 true HK1245401A1 (zh) 2018-08-24

Family

ID=55024274

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18104738.9A HK1245401A1 (zh) 2014-12-03 2018-04-11 鑑定、選擇和使用高治療潛力的t細胞表位

Country Status (6)

Country Link
US (3) US10317402B2 (zh)
EP (1) EP3227679A1 (zh)
AU (2) AU2015358387B2 (zh)
CA (2) CA3116369A1 (zh)
HK (1) HK1245401A1 (zh)
WO (1) WO2016090177A1 (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20230321A1 (es) 2015-07-01 2023-02-22 Immatics Biotechnologies Gmbh Nuevos peptidos y nuevas combinaciones de peptidos para el uso en la inmunoterapia contra el cancer de ovario y otros tipos de cancer
GB201511546D0 (en) * 2015-07-01 2015-08-12 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
MX2019010460A (es) 2017-03-03 2020-01-09 Treos Bio Zrt Plataforma de identificacion de peptidos inmunogenicos basada en poblacion.
EP3369431A1 (en) * 2017-03-03 2018-09-05 Treos Bio Kft Vaccine
US10767164B2 (en) 2017-03-30 2020-09-08 The Research Foundation For The State University Of New York Microenvironments for self-assembly of islet organoids from stem cells differentiation
WO2019033105A1 (en) * 2017-08-11 2019-02-14 The Regents Of The University Of California DETERMINING TISSUE PROPERTIES FOR CHARGED PARTICLE RADIATION THERAPY
CN107365373B (zh) * 2017-08-16 2020-11-03 漯河医学高等专科学校 靶向akap3的亲和肽p527
CN107325167B (zh) * 2017-08-16 2021-01-08 漯河医学高等专科学校 靶向akap3的亲和肽p296
CN107344964B (zh) * 2017-08-16 2020-10-27 漯河医学高等专科学校 靶向akap3的亲和肽p333
JP2021536487A (ja) * 2018-09-04 2021-12-27 トレオス バイオ リミテッド ペプチドワクチン
CA3142386A1 (en) * 2019-06-06 2020-12-10 Immatics Biotechnologies Gmbh Sorting with counter selection using sequence similar peptides
EP4438053A2 (en) * 2019-09-18 2024-10-02 Children's Medical Center Corporation An anaplastic lymphoma kinase (alk) cancer vaccine and methods of use
GB202004974D0 (en) 2020-04-03 2020-05-20 Treos Bio Ltd Coronavirus vaccine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0421355D0 (en) * 2004-09-24 2004-10-27 Univ Oslo Inhibitors
TW201008574A (en) * 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
US9062349B2 (en) 2011-04-14 2015-06-23 Texas Tech University System Composition and method for diagnosis and immunotherapy of prostate cancer
DK2817620T3 (en) * 2012-02-22 2016-09-05 Verik Bio Inc IMMUNTERY TREATMENT SYSTEM FOR TUMOR FORMATION AND PROGRESSION
AU2014216355A1 (en) 2013-02-12 2015-09-03 Texas Tech University System Composition and method for diagnosis and immunotherapy of lung cancer

Also Published As

Publication number Publication date
CA2969231C (en) 2021-06-08
AU2019253775A1 (en) 2019-11-07
CA3116369A1 (en) 2016-06-09
AU2015358387B2 (en) 2019-07-25
US11016091B2 (en) 2021-05-25
CA2969231A1 (en) 2016-06-09
US20160161486A1 (en) 2016-06-09
US20190353655A1 (en) 2019-11-21
US10317402B2 (en) 2019-06-11
EP3227679A1 (en) 2017-10-11
WO2016090177A1 (en) 2016-06-09
AU2015358387A1 (en) 2017-06-15
US20210278407A1 (en) 2021-09-09

Similar Documents

Publication Publication Date Title
HK1245401A1 (zh) 鑑定、選擇和使用高治療潛力的t細胞表位
IL251504B (en) car expression vector and t cells expressing car
ME03407B (me) Klaudin-6 specifični imunoreceptori i t-ćelijsкi epitopi
PT3137505T (pt) Combinação de lenalidomida e construção polipeptídica e utilizações desta
HK1231553A1 (zh) 功能性細胞狀態的鑒定
SG11201608943VA (en) Substituted 4-phenylpiperidines, their preparaiton and use
EP2986091A4 (en) CONTAINER FOR A DATA CENTER AND DATA CENTER
PT3131577T (pt) Células hospedeiras modificadas e suas utilizações
HK1258693A1 (zh) 高容量，封閉，冷凍保存細胞庫系統及其用途
SG11201610430QA (en) Growth-independent detection of cells
SG11201607173RA (en) Reactor system and use thereof
GB201403107D0 (en) Permeability and transformation of cells
IL247448A0 (en) Peptides and methods of use
GB201408173D0 (en) Personal vaporizer
GB201415379D0 (en) Gamma T cells and uses thereof
GB201412175D0 (en) Gamma T cells and uses thereof
GB201413650D0 (en) Wallets
AU353708S (en) Handbag